PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A polymorphism and the bacteria inside of us help dictate inflammation, antitumor activity

New findings show how an inactivating polymorphism in the TLR5 gene, which occurs in more than 1 out of 15 people, plays important role in progression of luminal breast cancer and ovarian cancer

A polymorphism and the bacteria inside of us help dictate inflammation, antitumor activity
2014-12-19
(Press-News.org) PHILADELPHIA - (Dec. 19, 2014) - A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in certain types of cancer, including a form of breast cancer as well as ovarian cancer, according to new research from The Wistar Institute that was published online by the journal Cancer Cell.

The research reveals a more explicit role about the symbiotic relationship humans have with the various bacteria that inhabit our body and their role during tumor progression.

"Our research indicates that interactions between the helpful bacteria in our bodies and immune cells at places situated away from tumors influence systemic responses in the host that alter how these tumors are able to progress," said José Conejo-Garcia, M.D., Ph.D., Associate Professor and Program Leader in the Tumor Microenvironment and Metastasis Program at The Wistar Institute and lead author of the study.

Humans are colonized with trillions of bacteria - known as commensal bacteria because there are benefits to having these bacteria in our bodies - that inhabit the gastrointestinal and respiratory tracts and our skin. These bacteria provide a first line of defense against infection. Recent research has found that interactions between these bacteria and the immune system are critical for providing important defenses against tumors occurring outside of the intestines.

In order for the immune system to recognize commensal as well as microscopic organisms that can cause disease - or pathogens - many of our cells are programmed to recognize pathogen-associated molecular patterns. At least 23% of the general public carries mutations in a group of pathogen recognition receptors called Toll-like receptor (TLR) genes. One of the most abundant polymorphisms, occurring in about 7.5% of the general population, or slightly more than one in fifteen people, which results in loss of function, is in TLR5. Although this polymorphism is found in completely healthy individuals, the people who do carry it are susceptible to illnesses such as Legionnaires disease, urinary tract infections, and bronchopulmonary dysplasia. Knowing that this variant could impact some immune responses, Wistar researchers set out to understand whether TLR5 signaling influences cancer.

The researchers found that TLR5 signaling influences certain types of cancer in different ways and is dependent upon the ability of the tumor to respond to interleukin 6 (IL-6), a small protein that can have both pro-inflammatory and anti-inflammatory properties. In individuals with functional TLR5 expression, commensal bacteria are able to stimulate IL-6 production, greater mobilization of myeloid-derived suppressor cells (MDSCs), which in turn transform gamma delta T cells, a T cell subset that possesses innate-like properties, to produce high amounts of galectin-1, a protein that suppresses antitumor immune activity and hastens tumor progression.

However, the researchers also showed that TLR5 signaling does not always mean that tumors will grow faster. TLR5-deficient mice with tumors that produce low levels of IL-6 have faster tumor progression. In this instance, IL-17, another interleukin closely associated with autoimmune diseases and inflammation, is consistently found in higher levels in TLR5-deficient mice that have tumors, but IL-17 only accelerates cancer when the tumors are unresponsive to IL-6.

Researchers observed these phenomena were dependent upon commensal bacteria. When commensal bacteria were removed with antibiotics, the differences in TLR5-mediated tumor progression were not observed. The researchers noted that the differences in inflammation and progression of tumors are recapitulated in TLR5-responsive and unresponsive patients with ovarian and luminal breast cancer. The researchers performed a survival analysis using data from The Cancer Genome Atlas (TCGA) on patients for whom data on their TLR5 status was known.

"Although independent sets of data and higher numbers of patients are needed, our data suggest that ovarian cancer reflects the evolution of IL-6-dependent tumors, while luminal breast cancer appears to become more aggressive in carriers of the polymorphism that abrogates TLR5 signaling," Conejo-Garcia said.

For ovarian cancer, which is associated with high levels of IL-6, researchers found a significantly higher number of TLR5-deficient patients alive six years after their initial diagnosis compared with patients with TLR5, indicating a correlation between the absence of TLR5 and improved survival. For luminal breast cancer, which is associated with low levels of IL-6, the long-term survival prospects were worse for patients without TLR5.

INFORMATION:

This work was supported by a Cancer Center Support Grant (CA010815. Other grants supporting this study included Grants R01CA157664, R01CA124515, R01CA178687, U54CA151662, and P30CA10815 and by Breast Cancer Alliance and Ovarian Cancer Research Fund Program Project Development awards. Members of the Conejo-Garcia laboratory who co-authored this study include Melanie R. Rutkowski, Tom L. Stephen, Nikolaos Svoronos, Michael J. Allegrezza, Amelia J. Tesone, Alfredo Perales-Puchalt, Eva Brencicova, Ximena Escovar-Fadul, Jenny M. Nguyen. Other co-authors included Rugang Zhang, another researcher at the Wistar Institute; Mark. G. Cadungog from the Helen F. Graham Cancer Center; Mariana Salatino and Gabriel A. Rabinovich from Laboratorio de Immunopatologia, Buenos Aires, Argentina; and Julia Tchou, and from the University of Pennsylvania.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today's Discoveries - Tomorrow's Cures. On the Web at http://www.wistar.org


[Attachments] See images for this press release:
A polymorphism and the bacteria inside of us help dictate inflammation, antitumor activity

ELSE PRESS RELEASES FROM THIS DATE:

Televised medical talk shows: Health education or entertainment?

Televised medical talk shows: Health education or entertainment?
2014-12-19
(Edmonton) For millions of people around the world, televised medical talk shows have become a daily viewing ritual. Programs such as The Dr. Oz Show and The Doctors have attracted massive followings as charismatic hosts discuss new medical research and therapies while offering viewers their own recommendations for better health. For show producers it's a winning ratings formula, but for viewers eager for a healthier life, the results aren't so clear cut. "The research supporting any of these recommendations is frequently absent, contradictory or of poor quality," says ...

Family criticizing your weight? You might add more pounds

2014-12-19
Women whose loved ones are critical of their weight tend to put on even more pounds, says a new study on the way people's comments affect our health. Professor Christine Logel from Renison University College at the University of Waterloo led the study, which appears in the December issue of the journal Personal Relationships. "When we feel bad about our bodies, we often turn to loved ones--families, friends and romantic partners--for support and advice. How they respond can have a bigger effect than we might think," said Professor Logel, who teaches social development ...

Yellowstone's thermal springs -- their colors unveiled

Yellowstones thermal springs -- their colors unveiled
2014-12-19
WASHINGTON D.C., December 19, 2014 - Researchers at Montana State University and Brandenburg University of Applied Sciences in Germany have created a simple mathematical model based on optical measurements that explains the stunning colors of Yellowstone National Park's hot springs and can visually recreate how they appeared years ago, before decades of tourists contaminated the pools with make-a-wish coins and other detritus. The model, and stunning pictures of the springs, appear today in the journal Applied Optics, which is published by The Optical Society (OSA). If ...

Technophobia may keep seniors from using apps to manage diabetes

2014-12-19
Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians are living with Type 2 diabetes, 2 million of whom are age 50 or older. The study, which appears in the online edition of the Journal of Diabetes Science and Technology, found that although more than 90 per cent of research participants owned a computer or had daily Internet access, just 18 per cent used applications on this technology to help manage ...

Making a good thing better

Making a good thing better
2014-12-19
The lithium-ion batteries that mobilize our electronic devices need to be improved if they are to power electric vehicles or store electrical energy for the grid. Berkeley Lab researchers looking for a better understanding of liquid electrolyte may have found a pathway forward. A team led by Richard Saykally, a chemist with Berkeley Lab's Chemical Sciences Division, David Prendergast, a theorist with Berkeley Lab's Molecular Foundry, and Steven Harris, a chemist with the Lab's Materials Sciences Division, found surprising results in the first X-ray absorption spectroscopy ...

The VuePod: Powerful enough for a gamer, made for an engineer

The VuePod: Powerful enough for a gamer, made for an engineer
2014-12-19
It's like a scene from a gamer's wildest dreams: 12 high-definition, 55-inch 3D televisions all connected to a computer capable of supporting high-end, graphics-intensive gaming. On the massive screen, images are controlled by a Wii remote that interacts with a Kinnect-like Bluetooth device (called SmartTrack), while 3D glasses worn by the user create dizzying added dimensions. But this real-life, computer-powered mega TV is not for gaming. It's for engineering. Welcome to Brigham Young University's VuePod, a 3D immersive visualization environment run by BYU's Department ...

Reducing emergency surgery cuts health care costs

2014-12-19
New research indicates that reducing emergency surgery for three common procedures by 10 percent could cut $1 billion in health care costs over 10 years. As hospitals and health systems increasingly focus on addressing the rising cost of health care in the United States, and with the expense of surgical care playing a major role, physician researchers and others across the healthcare industry are working to identify innovative ways to reduce surgical costs. In new findings published online in the journal Annals of Surgery on December 19, 2014, researchers determined ...

Scientists reveal breakthrough in optical fiber communications

Scientists reveal breakthrough in optical fiber communications
2014-12-19
Researchers from the University of Southampton have revealed a breakthrough in optical fibre communications. Academics from the University's Optoelectronics Research Centre (ORC) have collaborated with colleagues at Eblana Photonics Inc, in Ireland, to develop an approach that enables direct modulation of laser currents to be used to generate highly advanced modulation format signals. The research, published in the journal Nature Communications, explores a radically new approach to the generation of spectrally-efficient advanced modulation format signals as required ...

A vegetarian carnivorous plant

2014-12-19
Carnivorous plants catch and digest tiny animals in order and derive benefits for their nutrition. Interestingly the trend towards vegetarianism seems to overcome carnivorous plants as well. The aquatic carnivorous bladderwort, which can be found in many lakes and ponds worldwide, does not only gain profit from eating little animals but also by consuming algae and pollen grains. This results in survival in aquatic habitats where prey animals are rare, and in increased fitness if the animals and algae are caught in a well-balanced diet. An Austrian research group around ...

Epithelial tube contraction

Epithelial tube contraction
2014-12-19
Researchers at the Mechanobiology Institute (MBI), National University of Singapore (NUS) have identified a novel mechanosensitive regulation of epithelial tube contraction. These findings are published on 19 December 2014 in Current Biology (Pei Yi Tan and Ronen Zaidel-Bar. Transient membrane localization of SPV-1 drives cyclical actomyosin contractions in the C. elegans spermatheca, Current Biology, 19 Dec 2014, doi: 10.1016/j.cub.2014.11.033) Regulating tube constriction Many of the fundamental processes of life rely on biological structures known as epithelial ...

LAST 30 PRESS RELEASES:

Atomic nucleus excited with laser: a breakthrough after decades

Losing keys and everyday items ‘not always sign of poor memory’

People with opioid use disorder less likely to receive palliative care at end of life

New Durham University study reveals mystery of decaying exoplanet orbits

The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed

Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses

Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

[Press-News.org] A polymorphism and the bacteria inside of us help dictate inflammation, antitumor activity
New findings show how an inactivating polymorphism in the TLR5 gene, which occurs in more than 1 out of 15 people, plays important role in progression of luminal breast cancer and ovarian cancer